Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 SERVICES LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS FIVE FORCES
5 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: REGULATORY SCENARIO
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING DEMAND FOR CLINICAL TRIALS WORLDWIDE
6.1.2 INCREASING INCIDENCE OF CHRONIC DISEASES
6.1.3 GOVERNMENT FUNDS IN R&D INVESTMENTS
6.1.4 ADVANCEMENT OF TECHNOLOGY IN CLINICAL TRIALS SUPPLIES
6.2 RESTRAINTS
6.2.1 ADVERSE EFFECTS OF CLINICAL TRIALS
6.2.2 TRANSPORTATION ISSUE IN CLINICAL TRIAL SUPPLIES
6.2.3 HIGH COST ASSOCIATED WITH THE CLINICAL TRIALS
6.3 OPPORTUNITIES
6.3.1 INCREASING NEW DRUG DEVELOPMENT TRIALS IN EMERGING COUNTRIES
6.3.2 INCREASING DEMAND FOR INNOVATIVE SOLUTIONS IN CLINICAL TRIALS SERVICES
6.3.3 EVOLUTION IN SUPPLY CHAIN MANAGEMENT FOR CLINICAL TRIALS
6.4 CHALLENGES
6.4.1 LOWER PROCEDURE TIME OF CLINICAL TRIALS APPROVAL
6.4.2 LACK OF SKILLED PERSON TO OPERATE DEVICES DURING CLINICAL TRIALS
7 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES
7.1 OVERVIEW
7.2 STORAGE
7.3 MANUFACTURING
7.4 PACKAGING AND LABELLING
7.5 DISTRIBUTION
8 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASES
8.1 OVERVIEW
8.2 PHASE III
8.3 PHASE II
8.4 PHASE IV
8.5 PHASE I
9 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE
9.1 OVERVIEW
9.2 ONCOLOGY
9.3 CARDIOVASCULAR DISEASES
9.4 DERMATOLOGY
9.5 METABOLIC DISORDERS
9.6 INFECTIOUS DISEASES
9.7 RESPIRATORY DISEASES
9.8 CNS AND MENTAL DISORDERS
9.9 BLOOD DISORDERS
9.1 OTHERS
10 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY END USER
10.1 OVERVIEW
10.2 CONTRACT RESEARCH ORGANIZATIONS
10.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
11 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY REGION
11.1 ASIA-PACIFIC
11.1.1 CHINA
11.1.2 JAPAN
11.1.3 INDIA
11.1.4 SOUTH KOREA
11.1.5 AUSTRALIA
11.1.6 THAILAND
11.1.7 MALAYSIA
11.1.8 SINGAPORE
11.1.9 INDONESIA
11.1.10 PHILIPPINES
11.1.11 REST OF ASIA-PACIFIC
12 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 THERMO FISHER SCIENTIFIC INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENT
14.1.5.1 PARTNERSHIP
14.2 ALMAC GROUP
14.2.1 COMPANY SNAPSHOT
14.2.2 COMPANY SHARE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENTS
14.3 CATALENT INC.
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 SERVICE PORTFOLIO
14.3.5 RECENT DEVELOPMENT
14.3.5.1 SERVICE EXPANSION
14.4 CLINIGEN GROUP PLC
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENT
14.4.5.1 PARTNERSHIP
14.5 MOVIANTO
14.5.1 COMPANY SNAPSHOT
14.5.2 COMPANY SHARE ANALYSIS
14.5.3 SERVICE PORTFOLIO
14.5.4 RECENT DEVELOPMENT
14.5.4.1 ACQUISITION
14.6 PCI PHARMA SERVICES
14.6.1 COMPANY SNAPSHOT
14.6.2 SERVICE PORTFOLIO
14.6.3 RECENT DEVELOPMENTS
14.7 SHARP
14.7.1 COMPANY SNAPSHOT
14.7.2 SERVICE PORTFOLIO
14.7.3 RECENT DEVELOPMENT
14.8 ALIUM MEDICAL LIMITED
14.8.1 COMPANY SNAPSHOT
14.8.2 SERVICE PORTFOLIO
14.8.3 RECENT DEVELOPMENT
14.9 ANCILLARE, LP
14.9.1 COMPANY SNAPSHOT
14.9.2 SERVICE PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.1 BIOCAIR
14.10.1 COMPANY SNAPSHOT
14.10.2 SERVICE PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 BIONICAL LTD.
14.11.1 COMPANY SNAPSHOT
14.11.2 SERVICE PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.11.3.1 SERVICE LAUNCH
14.12 CLINICAL SUPPLIES MANAGEMENT HOLDINGS,INC
14.12.1 COMPANY SNAPSHOT
14.12.2 SERVICE PORTFOLIO
14.12.3 RECENT DEVELOPMENT
14.13 KLIFO
14.13.1 COMPANY SNAPSHOT
14.13.2 SERVICE PORTFOLIO
14.13.3 RECENT DEVELOPMENTS
14.13.3.1 ACQUISTION
14.14 MYONEX
14.14.1 COMPANY SNAPSHOT
14.14.2 SERVICE PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 PAREXEL INTERNATIONAL CORPORATION
14.15.1 COMPANY SNAPSHOT
14.15.2 SERVICE PORTFOLIO
14.15.3 RECENT DEVELOPMENT
14.15.3.1 COLLABORATION
14.16 SIRO CLINPHARM PRIVATE LIMITED
14.16.1 COMPANY SNAPSHOT
14.16.2 SERVICE PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 LOCATIONS OF REGISTERED STUDIES
TABLE 2 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 3 ASIA PACIFIC STORAGE IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 ASIA PACIFIC MANUFACTURING IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 ASIA PACIFIC PACKAGING AND LABELLING IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 ASIA PACIFIC DISTRIBUTION IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 8 ASIA PACIFIC PHASE III IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 ASIA PACIFIC PHASE II IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 10 ASIA PACIFIC PHASE IV IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 ASIA PACIFIC PHASE I IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 13 ASIA PACIFIC ONCOLOGY IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 ASIA PACIFIC CARDIOVASCULAR DISEASES IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 ASIA PACIFIC DERMATOLOGY IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 ASIA PACIFIC METABOLIC DISORDERS IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 ASIA PACIFIC INFECTIOUS DISEASES IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 ASIA PACIFIC RESPIRATORY DISEASES IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 ASIA PACIFIC CNS AND MENTAL DISORDERS IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 ASIA PACIFIC BLOOD DISORDERS IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 ASIA PACIFIC OTHERS IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 23 ASIA PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 ASIA PACIFIC PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 26 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 27 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 28 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 29 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 30 CHINA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 31 CHINA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 32 CHINA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 33 CHINA CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 34 JAPAN CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 35 JAPAN CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 36 JAPAN CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 37 JAPAN CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 38 INDIA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 39 INDIA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 40 INDIA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 41 INDIA CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 42 SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 43 SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 44 SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 45 SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 46 AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 47 AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 48 AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 49 AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 50 THAILAND CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 51 THAILAND CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 52 THAILAND CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 53 THAILAND CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 54 MALAYSIA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 55 MALAYSIA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 56 MALAYSIA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 57 MALAYSIA CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 58 SINGAPORE CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 59 SINGAPORE CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 60 SINGAPORE CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 61 SINGAPORE CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 62 INDONESIA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 63 INDONESIA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 64 INDONESIA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 65 INDONESIA CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 66 PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 67 PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 68 PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 69 PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 70 REST OF ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 ASIA PACIFIC CLINICAL TRIAL SUPLLIES MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC CLINICAL TRIAL SUPLLIES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 9 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: SEGMENTATION
FIGURE 10 NORTH AMERICA IS EXPECTED TO DOMINATE THE ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 11 RISING DEMAND FOR CLINICAL TRIALS WORLDWIDE AND INCREASING INCIDENCES OF DISEASES IS DRIVING THE ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 STORAGE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET
FIGURE 14 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY SERVICES, 2021
FIGURE 15 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY SERVICES, 2022-2029 (USD MILLION)
FIGURE 16 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY SERVICES, CAGR (2022-2029)
FIGURE 17 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY SERVICES, LIFELINE CURVE
FIGURE 18 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY CLINICAL PHASE, 2021
FIGURE 19 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY CLINICAL PHASE, 2022-2029 (USD MILLION)
FIGURE 20 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY CLINICAL PHASE, CAGR (2022-2029)
FIGURE 21 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY CLINICAL PHASE, LIFELINE CURVE
FIGURE 22 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY THERAPEUTIC USE, 2021
FIGURE 23 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY THERAPEUTIC USE, 2022-2029 (USD MILLION)
FIGURE 24 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY THERAPEUTIC USE, CAGR (2022-2029)
FIGURE 25 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY THERAPEUTIC USE, LIFELINE CURVE
FIGURE 26 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY END USER, 2021
FIGURE 27 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 28 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY END USER, CAGR (2022-2029)
FIGURE 29 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET: SNAPSHOT (2021)
FIGURE 31 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY COUNTRY (2021)
FIGURE 32 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY COUNTRY (2022 & 2029)
FIGURE 33 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 34 ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET: BY SERVICES (2022-2029)
FIGURE 35 ASIA PACIFIC CLINICAL TRIAL SUPPLIES MARKET: COMPANY SHARE 2021 (%)
